NeoControl approved for reimbursement by Turkey, Croatia governments

In October 2005, "Extracorporeal Magnetic Innervation for the Treatment of Urinary Incontinence" was issued in the reimbursement price list for the Turkish Medical Association and the Turkish government. This move affects more than 50 million Turkish citizens and widely opens the door for NeoControl treatment in Turkey. Neotonus is represented in Turkey by Hidromed Medical Devices Ltd. Co.

In August 2006, NeoControl Therapy was accepted for reimbursement by the Health Care Insurance Fund (HCIF) in Croatia. NeoControl has gained popularity through SIMBEX clinics in Zagreb, and this decision by the Croatia government sets the stage for many more placements of NeoControl in the country and neighboring regions. A national symposium was organized in November 2006. Neotonus is represented in the region by CELERIS, D.O.O. (Trg. J.F.Kennedya 6b 10000 Zagreb / +385 1 24 44 644)

For more information on these stories, or to contact either of these companies, please send an inquiry to Neotonus.

Neotonus exhibits at Arab Health 2006 in Dubai, UAE

From January 22-26, 2006, Neotonus management took part in the largest annual healthcare show in the Middle East, ARAB HEALTH. The company met with hundreds of potential distributors in the region, and as a result Neotonus has planned a massive launch of its products in Gulf countries throughout 2006. More information will be furnished as it is available.

New NeoControl study shows benefit in treating fecal incontinence

Thornton MJ, Kennedy ML, Lubowski DZ. Extracorporeal Magnetic Stimulation of the Pelvic Floor: Impact on Anorectal Function and Physiology. A Pilot Study. St. George Hospital, New South Wales, Australia. Dis Colon Rectum, October 2005. pp. 1945-1950. 

In the first peer-reviewed, published study of the effects of NeoControl on anorectal function and fecal incontinence, researchers at St. George Hospital in Australia studied 15 patients, who were treated twice weekly for five weeks. After six weeks, there was a statistically significant increase in resting and squeeze anal pressures and a significant subjective and objective improvement in continence scores.

For more information on this study, please contact Neotonus. 

NeoControl receives product approval in Russia, Brazil

Neotonus representatives Nayfeld Corporation (Russia, pictured right) and Instrumentarias Cientificas (Brazil) in early 2006 informed Neotonus management that product registration was confirmed final by the respective health authorities in their countries. 

Registration is expected in at least three other former-USSR nations during this year, Nayfeld Corporation reported. 

Meditech Interworld, one of Neotonus' liaisons for Latin America, has launched an advertising campaign in Brazil and expects to quickly penetrate the medical market. Brazil is the second Latin American nation to launch NeoControl since Fall 2005. Neotonus re-launched their products in Chile in October 2005.

Media Coverage: FIRST for Women Magazine

A hugely popular article entitled "No More Embarrassing Leaks" appeared in the July 4, 2005 issue of FIRST for Women Magazine, a popular USA publication. It documents one of the thousands of success stories generated by NeoControl therapy. For more information on this article, please click here.

NeoControl therapy is "safe & effective" in treating chronic pelvic pain syndrome, according to peer-reviewed study in The Journal of Urology

In a major clinical breakthrough, chief investigators at St. Mary's Hospital in London, United Kingdom, determined that electromagnetic therapy can be a very safe and effective treatment for chronic pelvic pain syndrome. The study was published in The Journal of Urology in June 2005. 

NeoControl therapy receives approval from China FDA

In June 2005, Chinese regulatory officials approved NeoControl Pelvic Floor Therapy for marketing and integration into the mainstream medical market in China. 

"We are proud to offer this highly effective, totally non-invasive therapy to one of the world's largest and growing markets," said Tony J. Morris, President & CEO of NEOTONUS, Inc.

NEOTONUS is in the process of creating an effective distribution network in China, led by Shanghai Function Medical Equipment.

NeoControl featured in Alternative Medicine magazine

In the April 2005 issue of the US publication Alternative Medicine, a feature article titled "May the Force Be With You" (Issue 76, pg. 74) outlined the recently escalated movement of practicing medicine utilizing pulsed electromagnetics. NeoControl was the primary entry listed under the "Devices to Know About" section. 

Indeed, ExMI technology has entered the medical mainstream.

For more information on this article and the publication, visit Alternative Medicine Online.

NeoControl featured in Croatian magazine Urologija

An article by Dr. Tomislav de Both, the first NeoControl customer in Croatia, has been published in the Croatian magazine Urologija. It marks the most widespread publicity in the Balkans to date for Neotonus. A copy of the article text can be found here.

AMPM Center in Pennsylvania Implements NeoTone therapy

Click the banner above to view the AMPM Neotonus page. For more information--including a list of NeoTone therapy centers near you, or for information regarding implementing NeoTone into your practice--send an inquiry here or call (800) 895-4298.